Niedergosgen, Switzerland

By Ernst Schmid-Gautschi, Heir

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: By Ernst Schmid-Gautschi, Heir. Retrieved from https://idiyas.com/inventor/by-ernst-schmid-gautschi-heir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: By Ernst Schmid-Gautschi, Heir: Innovator in Pyrrolidine Derivatives

Introduction

By Ernst Schmid-Gautschi is a notable inventor based in Niedergosgen, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrrolidine derivatives. His innovative approach has led to the development of compounds that are useful as analgesic agents.

Latest Patents

Schmid-Gautschi holds 1 patent for his work on pyrrolidine derivatives. The patent describes compounds of the formula ##STR1##, wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are defined in detail. These compounds are synthesized from the corresponding pyrrolines and have potential applications in pain relief.

Career Highlights

Throughout his career, Schmid-Gautschi has been associated with Hoffmann-La Roche Inc., a leading pharmaceutical company. His work has been instrumental in advancing the understanding and application of pyrrolidine derivatives in the medical field.

Collaborations

He has collaborated with notable colleagues such as Karl Bernauer and Karlheinz Pfoertner, contributing to various projects that enhance the efficacy of analgesic compounds.

Conclusion

By Ernst Schmid-Gautschi's contributions to the field of medicinal chemistry, particularly through his patent on pyrrolidine derivatives, highlight his role as an innovator in developing effective analgesic agents. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…